Drugs / Peptide Alarm Therapy
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05338658 | May 2023 → Jan 2027 expected | cancer, metastatic neoplasm | Masonic Cancer Center, University of Minnesota | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Peptide Alarm Therapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05338658 ↗ |
| Known as | PAT | “Peptide Alarm Therapy (PAT)” NCT05338658 ↗ |
| Route | Other | “PAT is given on Day 1 by IT injection” NCT05338658 ↗ |